{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP03904",
    "Peptide Name": "DASamP2 (synthetic AMPs, Lys-rich; variant of polybia-MPI, UCLL1)",
    "Source": "Amino acid substitution, insects, animal-derived, natural derivative",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "IKWKKLLRAAKRIL",
    "Sequence Length": 14,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Anti-MRSA"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 6,
    "Boman Index": 1.53,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "57%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is poorly similar (78.57%) toPolybia-MPI. K: 29%. GRAVY: -0.107; M Wt: 1737.242;  M formula: C83H150N25O15; mol ex coeff: 5550. A peptide mutant of polybia-MPI with the following mutations: D2K, D8R, and Q12R.Chemical modification:  C-termnal amidation.Activity: active against S. aureus USA300 MRSA (MIC 6.2 uM), E. coli (MIC 3.1 uM), B. subtilis (MIC 12.5 uM), and P. aeruginosa (MIC 6.25 uM).Toxicity: hemolytic HC50 75 uM.",
    "Author": "Menousek J, Mishra B, Hanke ML, Heim CE, Kielian T, Wang G. 2012",
    "Reference": "Int J Antimicrob Agents. 2012 May;39(5):402-6. doi: 10.1016/j.ijantimicag.2012.02.003.PubMed",
    "Title": "Database screening and in vivo efficacy of antimicrobial peptides against methicillin-resistant Staphylococcus aureus USA300"
  },
  "3D Structure": []
}